Pay in 4 interest-free payments of $43.25 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
used in cancer immunotherapy
The profile of extracted protein using traditional methods is usually incomplete
However proteomic characterization of the Golgi has been hindered by limited methodologies for obtaining enriched/purified Golgi fraction
bone marrow and spleen
Doramapimod Pembrolizumab used in cancer immunotherapyDoramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38=38 nM, for p38=65 nM, for p38=200 nM, and for p38=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0. 1 nM). Doramapimod also inhibits B Raf with an IC50 of 83 nM.
US$ 34.95
US$ 127.95
US$ 69.95